(Q33420406)

English

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Adaptive radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

Sophie D. Fosså

2

object named as

Fosså SD

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Lilleby W

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Waehre HR

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Olsen DR

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

735-743

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Recent results of management of palpable clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

National Patterns of Prostate Cancer Treatment by Radical Prostatectomy: Results of a Survey by the American College of Surgeons Commission on Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based study of long-term survival in patients with clinically localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life after palliative radiotherapy in patients with hormone‐resistant prostate cancer: single institution experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of quality of life after radical radiotherapy for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life outcomes in men treated for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impotence following radical prostatectomy: insight into etiology and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of urological morbidity on quality of life in patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary incontinence and sexual impotence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Definitive radiotherapy of prostatic cancer: the Norwegian Radium Hospital's experience (1976-1982).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low acute gastrointestinal and genitourinary toxicities in whole pelvic irradiation of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900475-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(98)00475-1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33420406&oldid=1536294134"